Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840058
mi
from
Everett, WA
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840058
mi
from
Everett, WA
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840019
mi
from
Tacoma, WA
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840019
mi
from
Tacoma, WA
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840256
mi
from
Beloit, WI
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840256
mi
from
Beloit, WI
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840293
mi
from
Madison, WI
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840293
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis Investigational Site Number 840282
mi
from
Wauwatosa, WI
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis Investigational Site Number 840282
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  2/19/2016
Sanofi-Aventis
mi
from
Buenos Aires,
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 2/19/2016
Sanofi-Aventis
mi
from
Buenos Aires,
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Scottsdale Healthcare Shea
mi
from
Scottsdale, AZ
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Scottsdale Healthcare Shea
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
MedStar Washington Hospital Center
mi
from
Washington,
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Mount Sinai School of Medicine Hospital
mi
from
New York, NY
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Mount Sinai School of Medicine Hospital
mi
from
New York, NY
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Pinnacle Health Cardiovascular Insititute
mi
from
Harrisburg, PA
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Pinnacle Health Cardiovascular Insititute
mi
from
Harrisburg, PA
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Medical University of South Carolina Hospital
mi
from
Charleston, SC
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Medical University of South Carolina Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Veterans Affairs, North Texas Health Care Systems
mi
from
Dallas, TX
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Veterans Affairs, North Texas Health Care Systems
mi
from
Dallas, TX
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
Spectrum Health System
mi
from
Grand Rapids, MI
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
Spectrum Health System
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated:  2/22/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Status: Enrolling
Updated: 2/22/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
University of Missouri Children's Hospital
mi
from
Columbia, MO
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
University of Missouri Children's Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
Hasbro Children's Hospital
mi
from
Providence, RI
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
Hasbro Children's Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
Microvascular Obstruction by Contrast-enhanced MRI Following Percutaneous Coronary Interventions
Status: Enrolling
Updated:  2/22/2016
Johns Hopkins Medical Institution
mi
from
Baltimore, MD
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
Microvascular Obstruction by Contrast-enhanced MRI Following Percutaneous Coronary Interventions
Status: Enrolling
Updated: 2/22/2016
Johns Hopkins Medical Institution
mi
from
Baltimore, MD
Click here to add this to my saved trials
Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial
Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial
Status: Enrolling
Updated:  2/23/2016
Athens Orthopedic Clinic, PA
mi
from
Athens, GA
Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial
Use of Compression Glove to Prevent Complications After Distal Radius Fractures: a Randomized Controlled Trial
Status: Enrolling
Updated: 2/23/2016
Athens Orthopedic Clinic, PA
mi
from
Athens, GA
Click here to add this to my saved trials
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated:  2/23/2016
The Hartford Hospital
mi
from
Hartford, CT
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated: 2/23/2016
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated:  2/23/2016
MedStar Washington Hospital Center
mi
from
Washington,
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated: 2/23/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated:  2/23/2016
St. Joseph's Hospitals
mi
from
Tampa, FL
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated: 2/23/2016
St. Joseph's Hospitals
mi
from
Tampa, FL
Click here to add this to my saved trials
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated:  2/23/2016
Legacy Good Samaritan
mi
from
Portland, OR
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated: 2/23/2016
Legacy Good Samaritan
mi
from
Portland, OR
Click here to add this to my saved trials
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated:  2/23/2016
Legacy Salmon Creek Medical Center
mi
from
Vancouver, WA
Assessment of an Endotracheal Tube Securement Device
Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
Status: Enrolling
Updated: 2/23/2016
Legacy Salmon Creek Medical Center
mi
from
Vancouver, WA
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Anaheim, CA
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Colorado Springs, CO
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
South Miami, FL
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Chapel Hill, NC
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Knoxville, TN
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Richmond, VA
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  2/23/2016
Novartis Investigative Site
mi
from
Geelong,
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 2/23/2016
Novartis Investigative Site
mi
from
Geelong,
Click here to add this to my saved trials
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
Status: Enrolling
Updated:  2/23/2016
United Heart and Vascular Clinic
mi
from
St. Paul, MN
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
Status: Enrolling
Updated: 2/23/2016
United Heart and Vascular Clinic
mi
from
St. Paul, MN
Click here to add this to my saved trials
Validation of Brain Oxygenation Monitor on Pediatric Patients
Validation of the CAS Medical System, Inc. FORE-SIGHT Near-Infrared Spectroscopy (NIRS) Monitor in Pediatric Subjects for Viscerosomatic Applications
Status: Enrolling
Updated:  2/24/2016
Duke University Health System
mi
from
Durham, NC
Validation of Brain Oxygenation Monitor on Pediatric Patients
Validation of the CAS Medical System, Inc. FORE-SIGHT Near-Infrared Spectroscopy (NIRS) Monitor in Pediatric Subjects for Viscerosomatic Applications
Status: Enrolling
Updated: 2/24/2016
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated:  2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
Alabama Resuscitation Center
mi
from
Birmingham, AL
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
Alabama Resuscitation Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
UCSD-San Diego Resuscitation Center
mi
from
San Diego, CA
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
UCSD-San Diego Resuscitation Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
mi
from
Portland, OR
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
The Pittsburgh Resuscitation Network, University of Pittsburgh
mi
from
Pittsburgh, PA
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
The Pittsburgh Resuscitation Network, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
Seattle-King County Center for Resuscitation Research, University of Washington
mi
from
Seattle, WA
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
Seattle-King County Center for Resuscitation Research, University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
Milwaukee Resuscitation Network, Medical College of Wisconsin
mi
from
Milwaukee, WI
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
Milwaukee Resuscitation Network, Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated:  2/25/2016
University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research
mi
from
Ottawa,
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)
Status: Enrolling
Updated: 2/25/2016
University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research
mi
from
Ottawa,
Click here to add this to my saved trials
A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
La Jolla, CA
A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials